Security key
29014R103
Eloxx Pharmaceuticals Inc - Common Stock, $0.01 par value per share (ELOX)
CUSIP: 29014R103
Q4 2022 13F Holders as of 31 Dec 2022
- Security type / class
- Equity / Common Stock, $0.01 par value per share
- Total 13F shares
- 14,626
- Total 13F value
- $27,000
- Share change
- -12,647,974
- SEC-reported price per share
- $1.85
- Number of holders
- 1
- Value change
- -$3,088,926
- Number of sells
- 24
- Shares outstanding
- 4,036,327
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2022
Institutions
1
Top holders
1
ELOX full security history
Ownership snapshot
Full 13F holder table
Eloxx Pharmaceuticals, Inc. SEC filings
Eloxx Pharmaceuticals, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of ELOX - Eloxx Pharmaceuticals Inc - Common Stock, $0.01 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Pontifax Management 4 G.P...
Disclosed value leader
VANGUARD GROUP INC
Comparable rows
0/15
Latest evidence
30 Sep 2022
3/4/5
13F
Highest disclosed value: $459,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
VANGUARD GROUP INC has the largest disclosed position value at $459K.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VANGUARD GROUP INC's linked filing trail.
Disclosed position value
Top 5
Pontifax Management 4 G.P. (2015)...
$443.9K
VANGUARD GROUP INC
$459K
MENORA MIVTACHIM HOLDINGS LTD.
$356K
AMERICAN FINANCIAL GROUP INC
$252K
Harel Insurance Investments & Fin...
$200K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Pontifax Management 4 G.P. (2015) Ltd. |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$443,946
616,592 shares
|
— | 13 May 2021 |
| VANGUARD GROUP INC |
13F
Company
|
—
denominator unverified
|
$459,000
2,704,513 shares
|
— | 30 Sep 2022 |
| MENORA MIVTACHIM HOLDINGS LTD. |
13F
Company
|
—
denominator unverified
|
$356,000
2,094,208 shares
|
— | 30 Sep 2022 |
| AMERICAN FINANCIAL GROUP INC |
13F
Company
|
—
denominator unverified
|
$252,000
1,480,000 shares
|
— | 30 Sep 2022 |
| Harel Insurance Investments & Financial Services Ltd. |
13F
Company
|
—
denominator unverified
|
$200,000
1,176,401 shares
|
— | 30 Sep 2022 |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
denominator unverified
|
$187,000
1,098,469 shares
|
— | 30 Sep 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
14,626
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
25
Q4 2022 holders
1
Holder diff
-24
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 value | Q4 2022 value | Value change | Value Chg % |
|---|